CD160 and BTLA: LIGHTs out for CD4+ T cells
- 1 February 2008
- journal article
- Published by Springer Nature in Nature Immunology
- Vol. 9 (2) , 122-124
- https://doi.org/10.1038/ni0208-122
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediatorNature Immunology, 2008
- Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responsesNature Medicine, 2008
- Negative and Positive Co-Signaling With Anti-BTLA (PJ196) and CTLA4Ig Prolongs Islet Allograft SurvivalTransplantation, 2007
- B and T lymphocyte attenuator interacts with CD3ζ and inhibits tyrosine phosphorylation of TCRζ complex during T‐cell activationImmunology & Cell Biology, 2007
- CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitmentInternational Immunology, 2007
- B and T lymphocyte attenuator regulates CD8+ T cell–intrinsic homeostasis and memory cell generationNature Immunology, 2007
- Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLABiochemical and Biophysical Research Communications, 2006
- Attenuating Lymphocyte ActivityJournal of Biological Chemistry, 2005
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003
- A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity.The Journal of Experimental Medicine, 1993